Solving the puzzle of Parkinson’s disease using induced pluripotent stem cells

Experimental Biology and Medicine

Volumn 239, Issue 11, 2014, Pages 1421-1432

  Zhao, Ping ^a   Luo, Zhiwei ^a   Tian, Weihua ^a   Yang, Jiayin ^a   Ibáñez, David P ^a   Huang, Zhijian ^a   Tortorella, Micky D ^a   Esteban, Miguel A ^a,b   Fan, Wenxia ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

disease modeling; dopaminergic neurons; induced pluripotent stem cells; Parkinson s disease; reprogramming

Indexed keywords

ALPHA SYNUCLEIN; LEUCINE RICH REPEAT KINASE 2;

ARTICLE; CANCER CELL LINE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN GENETICS; IN VITRO STUDY; MOLECULAR GENETICS; PARK2 GENE; PARKINSON DISEASE; PINK1 GENE; PLURIPOTENT STEM CELL; SNCA GENE; STEM CELL TRANSPLANTATION; CYTOLOGY; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

CELL DIFFERENTIATION; CYTOLOGICAL TECHNIQUES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MOLECULAR BIOLOGY; PARKINSON DISEASE;

EID: 84910098724     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214538588     Document Type: Article

References (79)

1. Fahn S.Description of Parkinson’s disease as a clinical syndrome.Ann NY Acad Sci. 2003;991:1-14
2. de Lau LM,Breteler MM.Epidemiology of Parkinson’s disease.Lancet Neurol. 2006;5:525-35
3. Braak H,Del Tredici K,Rub U,de Vos RA,Steur ENJ,Braak E.Staging of brain pathology related to sporadic Parkinson’s disease.Neurobiol Aging. 2003;24:197-211
4. Foltynie T,Hariz MI.Surgical management of Parkinson’s disease.Expert Rev Neurotherapeut. 2010;10:903-14
5. Poewe W,Antonini A,Zijlmans JC,Burkhard PR,Vingerhoets F.Levodopa in the treatment of Parkinson’s disease: an old drug still going strong.Clin Interv Aging. 2010;5:229-38
6. Barbeau AParkinson’s disease: clinical features and etiopathology. Amsterdam: Elsevier Science Publishers; 1986:87-152.
7. Bonifati V.Genetics of Parkinson’s disease—state of the art, 2013.Parkinsonism Relat Disord. 2014;20:S23-8
8. Martin I,Dawson VL,Dawson TM.Recent advances in the genetics of Parkinson’s disease.Annu Rev Genom Hum Genet. 2011;12:301-25
9. Cookson MR,Bandmann O.Parkinson’s disease: insights from pathways.Hum Mol Genet. 2010;19:R21-7
10. Smith WW,Pei Z,Jiang H,Moore DJ,Liang Y,West AB,Dawson VL,Dawson TM,Ross CA.Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.Proc Natl Acad Sci USA. 2005;102:18676-81
11. Rakovic A,Grunewald A,Seibler P,Ramirez A,Kock N,Orolicki S,Lohmann K,Klein C.Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.Hum Mol Genet. 2010;19:3124-37
12. Lee Y, Dawson VL and Dawson T M. Animal models of Parkinson’s disease: vertebrate genetics. vol. 2. Cold Spring Harbor Perspectives in Medicine, 2012.
13. Bove J,Perier C.Neurotoxin-based models of Parkinson’s disease.The Journal of Neuroscience. 2012;211:51-76
14. Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell. 2006;126:663-76
15. Zhou T,Benda C,Dunzinger S,Huang Y,Ho JC,Yang J,Wang Y,Zhang Y,Zhuang Q,Li Y,Bao X,Tse HF,Grillari J,Grillari-Voglauer R,Pei D,Esteban MA.Generation of human induced pluripotent stem cells from urine samples.Nat Protoc. 2012;7:2080-9
16. Hussein SM,Nagy AA.Progress made in the reprogramming field: new factors, new strategies and a new outlook.Curr Opin Genet Dev. 2012;22:435-43
17. Hartfield EM,Fernandes HJ,Vowles J,Cowley SA,Wade-Martins R.Cellular reprogramming: a new approach to modelling Parkinson’s disease.Biochem Soc Trans. 2012;40:1152-7
18. Park IH,Arora N,Huo H,Maherali N,Ahfeldt T,Shimamura A,Lensch MW,Cowan C,Hochedlinger K,Daley GQ.Disease-specific induced pluripotent stem cells.Cell. 2008;134:877-86
19. Devine MJ,Ryten M,Vodicka P,Thomson AJ,Burdon T,Houlden H,Cavaleri F,Nagano M,Drummond NJ,Taanman JW,Schapira AH,Gwinn K,Hardy J,Lewis PA,Kunath T.Parkinson’s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus.Nat Commun. 2011;2:440-440
20. Byers B,Cord B,Nguyen HN,Schule B,Fenno L,Lee PC,Deisseroth K,Langston JW,Pera RR,Palmer TD.SNCA triplication Parkinson’s patient’s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress.PloS One. 2011;6:e26159-e26159
21. Chung CY,Khurana V,Auluck PK,Tardiff DF,Mazzulli JR,Soldner F,Baru V,Lou Y,Freyzon Y,Cho S,Mungenast AE,Muffat J,Mitalipova M,Pluth MD,Jui NT,Schule B,Lippard SJ,Tsai LH,Krainc D,Buchwald SL,Jaenisch R,Lindquist S.Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons.Science. 2013;342:983-7
22. Ryan SD,Dolatabadi N,Chan SF,Zhang X,Akhtar MW,Parker J,Soldner F,Sunico CR,Nagar S,Talantova M,Lee B,Lopez K,Nutter A,Shan B,Molokanova E,Zhang Y,Han X,Nakamura T,Masliah E,Yates JR III,Nakanishi N,Andreyev AY,Okamoto S,Jaenisch R,Ambasudhan R,Lipton SA.Isogenic human iPSC Parkinson’s model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription.Cell. 2013;155:1351-64
23. Nguyen HN,Byers B,Cord B,Shcheglovitov A,Byrne J,Gujar P,Kee K,Schule B,Dolmetsch RE,Langston W,Palmer TD,Pera RR.LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.Cell Stem Cell. 2011;8:267-80
24. Sanchez-Danes A,Richaud-Patin Y,Carballo-Carbajal I,Jimenez-Delgado S,Caig C,Mora S,Di Guglielmo C,Ezquerra M,Patel B,Giralt A,Canals JM,Memo M,Alberch J,Lopez-Barneo J,Vila M,Cuervo AM,Tolosa E,Consiglio A,Raya A.Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease.EMBO Mol Med. 2012;4:380-95
25. Cooper O,Seo H,Andrabi S,Guardia-Laguarta C,Graziotto J,Sundberg M,McLean JR,Carrillo-Reid L,Xie Z,Osborn T,Hargus G,Deleidi M,Lawson T,Bogetofte H,Perez-Torres E,Clark L,Moskowitz C,Mazzulli J,Chen L,Volpicelli-Daley L,Romero N,Jiang H,Uitti RJ,Huang Z,Opala G,Scarffe LA,Dawson VL,Klein C,Feng J,Ross OA,Trojanowski JQ,Lee VM,Marder K,Surmeier DJ,Wszolek ZK,Przedborski S,Krainc D,Dawson TM,Isacson O.Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease.Sci Transl Med. 2012;4:141ra90-141ra90
26. Liu GH,Qu J,Suzuki K,Nivet E,Li M,Montserrat N,Yi F,Xu X,Ruiz S,Zhang W,Wagner U,Kim A,Ren B,Li Y,Goebl A,Kim J,Soligalla RD,Dubova I,Thompson J,Yates J III,Esteban CR,Sancho-Martinez I,Izpisua Belmonte JC.Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.Nature. 2012;491:603-7
27. Reinhardt P,Schmid B,Burbulla LF,Schondorf DC,Wagner L,Glatza M,Hoing S,Hargus G,Heck SA,Dhingra A,Wu G,Muller S,Brockmann K,Kluba T,Maisel M,Kruger R,Berg D,Tsytsyura Y,Thiel CS,Psathaki OE,Klingauf J,Kuhlmann T,Klewin M,Muller H,Gasser T,Scholer HR,Sterneckert J.Genetic correction of a LRRK2 mutation in human iPSCs links Parkinsonian neurodegeneration to ERK-dependent changes in gene expression.Cell Stem Cell. 2013;12:354-67
28. Orenstein SJ,Kuo SH,Tasset I,Arias E,Koga H,Fernandez-Carasa I,Cortes E,Honig LS,Dauer W,Consiglio A,Raya A,Sulzer D,Cuervo AM.Interplay of LRRK2 with chaperone-mediated autophagy.Nat Neurosci. 2013;16:394-406
29. Su YC,Qi X.Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation.Hum Mol Genet. 2013;22:4545-61
30. Sanders LH,Laganiere J,Cooper O,Mak SK,Vu BJ,Huang YA,Paschon DE,Vangipuram M,Sundararajan R,Urnov FD,Langston JW,Gregory PD,Zhang HS,Greenamyre JT,Isacson O,Schule B.LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson’s disease patients: reversal by gene correction.Neurobiol Dis. 2014;62:381-6
31. Seibler P,Graziotto J,Jeong H,Simunovic F,Klein C,Krainc D.Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells.J Neurosci. 2011;31:5970-6
32. Rakovic A,Shurkewitsch K,Seibler P,Grunewald A,Zanon A,Hagenah J,Krainc D,Klein C.PTEN-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem (iPS) cell-derived neurons.J Biol Chem. 2012;4:380-95
33. Miller JD,Ganat YM,Kishinevsky S,Bowman RL,Liu B,Tu EY,Mandal PK,Vera E,Shim JW,Kriks S,Taldone T,Fusaki N,Tomishima MJ,Krainc D,Milner TA,Rossi DJ,Studer L.Human iPSC-based modeling of late-onset disease via progerin-induced aging.Cell Stem Cell. 2013;13:691-705
34. Jiang H,Ren Y,Yuen EY,Zhong P,Ghaedi M,Hu Z,Azabdaftari G,Nakaso K,Yan Z,Feng J.Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.Nat Commun. 2012;3:668-668
35. Imaizumi Y,Okada Y,Akamatsu W,Koike M,Kuzumaki N,Hayakawa H,Nihira T,Kobayashi T,Ohyama M,Sato S,Takanashi M,Funayama M,Hirayama A,Soga T,Hishiki T,Suematsu M,Yagi T,Ito D,Kosakai A,Hayashi K,Shouji M,Nakanishi A,Suzuki N,Mizuno Y,Mizushima N,Amagai M,Uchiyama Y,Mochizuki H,Hattori N,Okano H.Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.Mol Brain. 2012;5:35-35
36. Aboud AA,Tidball AM,Kumar KK,Neely MD,Ess KC,Erikson KM,Bowman AB.Genetic risk for Parkinson’s disease correlates with alterations in neuronal manganese sensitivity between two human subjects.Neurotoxicology. 2012;33:1443-9
37. Soldner F,Hockemeyer D,Beard C,Gao Q,Bell GW,Cook EG,Hargus G,Blak A,Cooper O,Mitalipova M,Isacson O,Jaenisch R.Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.Cell. 2009;136:964-77
38. Elkabetz Y,Panagiotakos G,Al Shamy G,Socci ND,Tabar V,Studer L.Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage.Genes Dev. 2008;22:152-65
39. Kim BK,Kim SE,Shim JH,Woo DH,Gil JE,Kim SK,Kim JH.Neurogenic effect of vascular endothelial growth factor during germ layer formation of human embryonic stem cells.FEBS Lett. 2006;580:5869-74
40. Perrier AL,Tabar V,Barberi T,Rubio ME,Bruses J,Topf N,Harrison NL,Studer L.Derivation of midbrain dopamine neurons from human embryonic stem cells.Proc Natl Acad Sci USA. 2004;101:12543-8
41. Roy NS,Cleren C,Singh SK,Yang L,Beal MF,Goldman SA.Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.Nat Med. 2006;12:1259-68
42. Sonntag KC,Pruszak J,Yoshizaki T,van Arensbergen J,Sanchez-Pernaute R,Isacson O.Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.Stem Cell. 2007;25:411-8
43. Sanchez-Danes A,Consiglio A,Richaud Y,Rodriguez-Piza I,Dehay B,Edel M,Bove J,Memo M,Vila M,Raya A,Belmonte JCI.Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.Hum Gene Ther. 2012;23:56-69
44. Yan Y,Yang D,Zarnowska ED,Du Z,Werbel B,Valliere C,Pearce RA,Thomson JA,Zhang SC.Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.Stem Cell. 2005;23:781-90
45. Okada Y,Matsumoto A,Shimazaki T,Enoki R,Koizumi A,Ishii S,Itoyama Y,Sobue G,Okano H.Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells.Stem Cell. 2008;26:3086-98
46. Neely MD,Litt MJ,Tidball AM,Li GG,Aboud AA,Hopkins CR,Chamberlin R,Hong CC,Ess KC,Bowman AB.DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction.ACS Chem Neurosci. 2012;3:482-91
47. Kriks S,Shim JW,Piao J,Ganat YM,Wakeman DR,Xie Z,Carrillo-Reid L,Auyeung G,Antonacci C,Buch A,Yang L,Beal MF,Surmeier DJ,Kordower JH,Tabar V,Studer L.Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease.Nature. 2011;480:547-51
48. Chambers SM,Fasano CA,Papapetrou EP,Tomishima M,Sadelain M,Studer L.Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.Nat Biotechnol. 2009;27:275-80
49. Cooper O,Hargus G,Deleidi M,Blak A,Osborn T,Marlow E,Lee K,Levy A,Perez-Torres E,Yow A,Isacson O.Differentiation of human ES and Parkinson’s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.Mol Cell Neurosci. 2010;45:258-66
50. Frank-Kamenetsky M,Zhang XM,Bottega S,Guicherit O,Wichterle H,Dudek H,Bumcrot D,Wang FY,Jones S,Shulok J,Rubin LL,Porter JA.Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.J Biol. 2002;1:10-10
51. Chen JK,Taipale J,Young KE,Maiti T,Beachy PA.Small molecule modulation of smoothened activity.Proc Natl Acad Sci USA. 2002;99:14071-6
52. Li W,Sun W,Zhang Y,Wei W,Ambasudhan R,Xia P,Talantova M,Lin T,Kim J,Wang X,Kim WR,Lipton SA,Zhang K,Ding S.Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors.Proc Natl Acad Sci USA. 2011;108:8299-304
53. Kim JE,O’Sullivan ML,Sanchez CA,Hwang M,Israel MA,Brennand K,Deerinck TJ,Goldstein LS,Gage FH,Ellisman MH,Ghosh A.Investigating synapse formation and function using human pluripotent stem cell-derived neurons.Proc Natl Acad Sci USA. 2011;108:3005-10
54. Mak SK, Huang YA, Iranmanesh S, Vangipuram M, Sundararajan R, Nguyen L, Langston JW and Schule B. Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cell Int 2012; 31(16):5970--6.
55. Buganim Y,Faddah DA,Jaenisch R.Mechanisms and models of somatic cell reprogramming.Nat Rev Genet. 2013;14:427-39
56. Liang G,Zhang Y.Genetic and epigenetic variations in iPSCs: potential causes and implications for application.Cell Stem Cell. 2013;13: 149-59
57. Hu Q,Friedrich AM,Johnson LV,Clegg DO.Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.Stem Cell. 2010;28:1981-91
58. Polo JM,Liu S,Figueroa ME,Kulalert W,Eminli S,Tan KY,Apostolou E,Stadtfeld M,Li Y,Shioda T,Natesan S,Wagers AJ,Melnick A,Evans T,Hochedlinger K.Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.Nat Biotechnol. 2010;28:848-55
59. Laurent LC,Ulitsky I,Slavin I,Tran H,Schork A,Morey R,Lynch C,Harness JV,Lee S,Barrero MJ,Ku S,Martynova M,Semechkin R,Galat V,Gottesfeld J,Izpisua Belmonte JC,Murry C,Keirstead HS,Park HS,Schmidt U,Laslett AL,Muller FJ,Nievergelt CM,Shamir R,Loring JF.Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.Cell Stem Cell. 2011;8:106-18
60. Bock C,Kiskinis E,Verstappen G,Gu H,Boulting G,Smith ZD,Ziller M,Croft GF,Amoroso MW,Oakley DH,Gnirke A,Eggan K,Meissner A.Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.Cell. 2011;144:439-52
61. Boulting GL,Kiskinis E,Croft GF,Amoroso MW,Oakley DH,Wainger BJ,Williams DJ,Kahler DJ,Yamaki M,Davidow L,Rodolfa CT,Dimos JT,Mikkilineni S,MacDermott AB,Woolf CJ,Henderson CE,Wichterle H,Eggan K.A functionally characterized test set of human induced pluripotent stem cells.Nat Biotechnol. 2011;29:279-86
62. Hu BY,Weick JP,Yu J,Ma LX,Zhang XQ,Thomson JA,Zhang SC.Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.Proc Natl Acad Sci USA. 2010;107:4335-40
63. Gaj T,Gersbach CA,Barbas CF III.ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.Trends Biotechnol. 2013;31:397-405
64. Soldner F,Laganiere J,Cheng AW,Hockemeyer D,Gao Q,Alagappan R,Khurana V,Golbe LI,Myers RH,Lindquist S,Zhang L,Guschin D,Fong LK,Vu BJ,Meng X,Urnov FD,Rebar EJ,Gregory PD,Zhang HS,Jaenisch R.Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.Cell. 2011;146:318-31
65. Gupta A,Meng X,Zhu LJ,Lawson ND,Wolfe SA.Zinc finger protein-dependent and -independent contributions to the in vivo off-target activity of zinc finger nucleases.Nucleic Acids Res. 2011;39:381-92
66. Fu Y,Foden JA,Khayter C,Maeder ML,Reyon D,Joung JK,Sander JD.High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.Nat Biotechnol. 2013;31:822-6
67. Mekhoubad S,Bock C,de Boer AS,Kiskinis E,Meissner A,Eggan K.Erosion of dosage compensation impacts human iPSC disease modeling.Cell Stem Cell. 2012;10:595-609
68. Brinkman AB,Roelofsen T,Pennings SW,Martens JH,Jenuwein T,Stunnenberg HG.Histone modification patterns associated with the human X chromosome.EMBO Rep. 2006;7:628-34
69. Yu J,Hu K,Smuga-Otto K,Tian S,Stewart R,Slukvin II,Thomson JA.Human induced pluripotent stem cells free of vector and transgene sequences.Science. 2009;324:797-801
70. Sandoe J,Eggan K.Opportunities and challenges of pluripotent stem cell neurodegenerative disease models.Nat Neurosci. 2013;16:780-9
71. Croisier E,Graeber MB.Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration.Acta Neuropathol. 2006;112:517-30
72. Lobsiger CS,Cleveland DW.Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease.Nat Neurosci. 2007;10:1355-60
73. Ransom BR,Kunis DM,Irwin I,Langston JW.Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.Neurosci Lett. 1987;75:323-8
74. Zhou W,Lee YM,Guy VC,Freed CR.Embryonic stem cells with GFP knocked into the dopamine transporter yield purified dopamine neurons in vitro and from knock-in mice.Stem Cell. 2009;27:2952-61
75. Pang ZP,Yang N,Vierbuchen T,Ostermeier A,Fuentes DR,Yang TQ,Citri A,Sebastiano V,Marro S,Sudhof TC,Wernig M.Induction of human neuronal cells by defined transcription factors.Nature. 2011;476:220-3
76. Zhang Y,Pak C,Han Y,Ahlenius H,Zhang Z,Chanda S,Marro S,Patzke C,Acuna C,Covy J,Xu W,Yang N,Danko T,Chen L,Wernig M,Sudhof TC.Rapid single-step induction of functional neurons from human pluripotent stem cells.Neuron. 2013;78:785-98
77. Chinta SJ,Lieu CA,Demaria M,Laberge RM,Campisi J,Andersen JK.Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson’s disease?.J Intern Med. 2013;273:429-36
78. Lancaster MA,Renner M,Martin CA,Wenzel D,Bicknell LS,Hurles ME,Homfray T,Penninger JM,Jackson AP,Knoblich JA.Cerebral organoids model human brain development and microcephaly.Nature. 2013;501:373-9
79. Qiang L,Fujita R,Abeliovich A.Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.Neuron. 2013;78:957-69